We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
The characteristics, diagnosis, management, surveillance and epidemiology of meningococcal disease.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Clinical advice on West Nile virus including symptoms, diagnosis and epidemiology.
How to spot contagious equine metritis, what to do if you suspect it and measures to prevent its spread.
New genetic therapy approved for SOD1-ALS brings targeted treatment option to patients in the UK
You must tell DVLA if you have motor neurone disease - also known as amyotrophic lateral sclerosis (ALS) - download the correct form to let them know
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).